More sites now recruiting for ZEN003694 NCT02705469 trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

More sites now recruiting for ZEN003694 NCT02705469 trial

posted on Jun 09, 2016 01:27PM

7 out of 8 sites now recruiting for ZEN003694 NCT02705469 trial. The only one not recruiting yet is UCLA.